Japan Science & Technology Agency
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 8, 2026), Japan Science & Technology Agency reported 12 stock positions worth $4.8 billion. Its top holding was Ishr Ibx Usd Invgd CB ETF-Ui (LQD) at 19.3% of the portfolio, followed by Ishr Ibx Usd Hiyld CB ETF-Ui (HYG, 17.2%) and iShares Core S&P 500 ETF (IVV, 11.5%). Compared with Q4 2025, it added to 1 and reduced 4. The biggest buy was iShares Core MSCI Emerging (IEMG, shares +51%) and the biggest sale iShares Core S&P 500 ETF (IVV, shares −28%).
- Most Recent 13F
- Q2 2026
- Location
- TOKYO, M0
- CIK
- 0001948391
- Portfolio Value
- $4.8B (Q1 2026)
- SEC Filing
- 0001948391-26-000003 ↗ filed May 8, 2026
Holdings Value
Holdings 12 stocks · $4.8B
| LQD Ishr Ibx Usd Invgd CB ETF-Ui | 19.27% | 8,506,450 | $927.1M | Reduce -17.5% |
| HYG Ishr Ibx Usd Hiyld CB ETF-Ui | 17.18% | 10,390,626 | $826.7M | No change |
| IVV iShares Core S&P 500 ETF | 11.51% | 847,800 | $553.8M | Reduce -27.6% |
| RSP Invesco S&P 500 Equal Weight | 11.35% | 2,844,812 | $546.0M | Reduce -25.0% |
| USHY iShares Broad Usd High Yield | 10.96% | 14,319,906 | $527.5M | No change |
| IEMG iShares Core MSCI Emerging | 6.70% | 4,620,513 | $322.3M | Add +51.5% |
| JNK SS SPDR BB High Yield Bond | 5.77% | 2,900,000 | $277.6M | No change |
| EMB iShares JP Morgan Usd Emergi | 4.88% | 2,500,000 | $234.8M | No change |
| SHYG iShares 0-5 YR HY Corp. Bond | 3.91% | 4,450,000 | $188.3M | No change |
| QQQ Invesco QQQ Trust Series 1 | 3.83% | 319,081 | $184.2M | Reduce -20.8% |
| VUG Vanguard Mrngstar GR ETF-Sui | 3.19% | 350,953 | $153.3M | No change |
| VTV Vanguard Mrngstr Val ETF-Aui | 1.46% | 357,328 | $70.1M | No change |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
| IEMG iShares Core MSCI Emerging | Add +51.5% | 6.70% | +2.93 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $5.3B | HYG, LQD, IVV, RSP, USHY |
| Q1 2026 | 12 | $4.8B | LQD, HYG, IVV, RSP, USHY |
| Q4 2025 | 12 | $5.4B | LQD, HYG, IVV, RSP, USHY |
| Q3 2025 | 13 | $5.6B | LQD, HYG, IVV, RSP, USHY |
| Q2 2025 | 13 | $6.3B | LQD, HYG, IVV, RSP, VCIT |
| Q1 2025 | 13 | $6.5B | LQD, HYG, IVV, RSP, VCIT |
| Q4 2024 | 11 | $5.8B | LQD, HYG, VCIT, VCSH, IGSB |
| Q3 2024 | 13 | $7.6B | LQD, VCSH, VCIT, HYG, IGSB |
| Q2 2024 | 12 | $7.2B | LQD, VCSH, VCIT, HYG, IGSB |
| Q1 2024 | 12 | $8.1B | VCSH, LQD, VCIT, HYG, IGSB |